Loading…
Loading…
EQUITY / NYSE · XASE
NeurAxis, Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗7.2 USD · 0.6993%
Observed: Oct 5, 2026, 8:00 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 7.15 USD · Volume 53,783
251 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Revenue | 1,928,695 USD | 894,086 USD | +115.72% |
| Operating profit | -2,124,712 USD | -1,717,858 USD | — |
| Net income | -2,085,746 USD | -1,690,418 USD | — |
| Cash and cash equivalents | 8,322,258 USD | — | — |
| Total liabilities | 3,261,107 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 8,322,258 USD | — | — | 4,965,072 USD | 4,965,072 USD | 4,377,109 USD | — | — |
| Gross profitIncome statement | 1,656,122 USD | 3,045,639 USD | — | — | 3,006,366 USD | 675,927 USD | 2,179,890 USD | 747,443 USD |
| Net incomeIncome statement | -2,085,746 USD | -3,847,178 USD | -1,761,432 USD | — | -7,800,555 USD | -2,122,796 USD | -6,091,898 USD | -1,690,418 USD |
| Operating profitIncome statement | -2,124,712 USD | -3,865,391 USD | — | — | -7,829,908 USD | -2,100,085 USD | -6,113,040 USD | -1,717,858 USD |
| RevenueIncome statement | 1,928,695 USD | 3,536,578 USD | — | — | 3,569,282 USD | 811,414 USD | 2,601,155 USD | 894,086 USD |
| Total assetsBalance sheet | 9,996,160 USD | — | — | 6,404,036 USD | 6,404,036 USD | 5,776,363 USD | — | — |
| Total equityBalance sheet | 6,735,053 USD | — | 5,747,550 USD | 3,399,372 USD | 3,399,372 USD | 2,284,941 USD | — | 4,253,294 USD |
| Total liabilitiesBalance sheet | 3,261,107 USD | — | — | 3,004,664 USD | 3,004,664 USD | 3,491,422 USD | — | — |
| Capital expendituresCash flow statement | — | 6,303 USD | — | — | 31,150 USD | — | 25,288 USD | — |
| Financing cash flowCash flow statement | — | 5,622,794 USD | — | — | 7,832,195 USD | — | 5,204,211 USD | — |
| Investing cash flowCash flow statement | — | -6,303 USD | — | — | -131,150 USD | 0 USD | -25,288 USD | — |
| Operating cash flowCash flow statement | — | -2,259,305 USD | — | — | -6,432,843 USD | — | -4,498,684 USD | — |
| Report source | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 08/11/2026 | Open report ↗ Published: 03/19/2026 | Open report ↗ Published: 11/10/2025 | Open report ↗ Published: 11/10/2025 | Open report ↗ Published: 08/11/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.